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CHAPTER I 
INTRODUCTION 
Significance of the Study 
The protein portion of the daily dietary intake represents the most 
important dietary problem in the patient with chronic renal disease (12). 
Since 1836, many dietary regimens have been advocated in an attempt to 
deal effectively with this problem. Early attempts at dietary manage-
ment were based on the principle of restricting the daily protein intake 
in an effort to diminish the accumulation of end-products of protein 
metabolism, which is chiefly urea (9). Although the exogenous protein 
intake is closely related to the degree of uremia, even in the absence 
of dietary protein intake, endogenous tissue catabolism will raise blood 
urea levels and result in the accumulation of nitrogenous end-products 
which adversely affect the patient's health (9). 
Because of this latter consideration, researchers have become 
interested in the substitution of alpha-keto analogues of essential 
amino acids for the amino acids as a therapy for uremia. According to 
Walser et al. (18), the rationale for this type of therapy is based on 
several earlier observations: 
a.) urea is continually degraded to ammonia and 
carbon dioxide by intestinal urease in normal subjects, as 
well as in patients with uremia; b.) uremic patients respond 
favorably to restriction of dietary protein; c.) urea or 
ammonia can be utilized for protein synthesis, particularly 
when dietary protein is restricted; and d.) alpha-keto 
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analogues of most of the essential amino acids can promote 
growth in rats fed diets devoid of the corresponding amino 
acid. (18, p. 678) 
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The utilization of the keto acid analogues of essential amino acids 
has important practical implications in the treatment of uremia. If 
these compounds could, in appropriate amounts, replace all or most of 
the essential amino acids, a synthetic diet could be produced which 
would be virtually nitrogen-free. Such a diet would have an advantage 
over current or natural diets in that it would maximize reutilization of 
the patient's available ammonia nitrogen, thereby reducing the amount of 
urea nitrogen formed for excretion (1). 
For the growing rat, the essential amino acids can, indeed, be 
replaced by their alpha-keto acid analogues without reducing the 
animal's rate of growth if adequate non-specific nitrogen is provided 
(21). Given the carbon skeleton, the rat by amination or transamination 
converts the analogue to the essential amino acid and utilizes nitrogen 
from the ammonia pool in the process. In most studies, the non-
essential nitrogen to be used for the conversion of the keto analogues 
to amino acids has been furnished in the form of dietary ammonium salts. 
If not supplemented in the diet, the reserve of the ammonia pool would 
be used. 
In uremia, this surplus of ammonia can be used for synthesis of 
essential amino acids. Richards et al. (13) found that in patients 
suffering with chronic renal failure, the amount of nitrogen urea 
cycled through ammonia was sufficient to supply the nitrogen required 
for synthesis of essential amino acids. Since the amount of urea 
recycled is a function of blood urea concentration, it would appear then 
that the patient would benefit not only from the uptake of ammonia for 
amino acid synthesis but also from reducing recycling of urea (12). 
Purpose of the Study 
Hence, the benefit of alpha-keto acid analogue therapy may be two-
fold: (1) in reducing blood urea levels and thus ameliorating the 
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uremic syndrome associated with high blood urea nitrogen levels and (2) 
in improving the nutritional status of the individual in regard to pro-
tein synthesis. The purpose of this study was to observe the effective-
ness of substitution of, the alpha-keto acid analogue of phenylalanine 
for tyrosine and phenylalanine in the diet of uremic rats as measured by 
weight gain and blood urea nitrogen. 
Objectives of the Study 
The objectives of this study were: 
1. To establish a time line for the development of uremia in rats 
following a five-sixths partial nephrectomy. 
2. To determine if surgically-induced uremic rats could convert an 
alpha-keto acid analogue of an essential amino acid to the 
amino acid sufficiently to gain weight rapidly. 
3. To determine if the conversion of the alpha-keto acid analogue 
to the essential amino acid would occur rapidly enough to 
reduce the urea nitrogen in the bloodstream, which would indi-
cate that this clinical syndrome of uremia was being alleviated 
by alpha-keto analogue use. 
CHAPTER II 
REVIEW OF LITERATURE 
Urea is the chief nitrogenous waste product of protein metabolism. 
It is formed in the liver by the deamination of amino acids and carried 
to the kidneys by the blood (11). The concentration of urea in the 
urine depends on 1.) the concentration of urea in plasma, 2.) the rate 
of glomerular filtration, 3.) tubular secretion, and 4.) tubular 
reabsorption (9). In the case of chronic renal disease, where there is 
a progressive loss of functional glomeruli, there will be a decrease in 
urea filtration with a subsequent rise in blood urea nitrogen (BUN) 
levels. As urea nitrogen concentration increases in the blood, toxic 
substances, i.e., ammonia, associated with protein catabolism will also 
accumulate. Eventually a point is reached when the individual cannot 
tolerate the excessive levels of these toxins in the blood stream and 
the individual will become comatose (9). 
The underlying mechanisms by which elevated urea levels are sharply 
lowered through elimination of protein from the diet of the azotemic 
patient are not well understood. Certainly, the amount of excess nitro-
gen intake is reduced. However, the use of urea nitrogen as a direct 
substitute is not possible. Yet it is postulated that utilization of 
urea for anabolic purposes is responsible for most of the improvement 
(9). Evidence of the ability to incorporate nitrogen from urea into 
body protein has been found in several species. Davies and Kornberg (3) 
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found that liver protein of the cat was labeled with Nl5 after being fed 
labeled urea with a low protein diet. Lui et al. (10) showed that 
liver, kidney and blood protein were labeled with the isotope when Nl5_ 
labeled urea was fed to growing pigs with a low protein diet. Rose and 
Dekker (14) also demonstrated that urea nitrogen was utilized for 
synthesis of non-essential amino acids by the growing rat when no pro-
tein nitrogen was available. 
Using these earlier animal studies as guidelines, Giordana (6) 
postulated that if urea, under certain conditions, were used for protein 
synthesis, patients suffering from chronic renal disease could utilize 
th.eir own urea for anabolic purposes. This assumption led to the 
development and clinical application of diets restricted to proteins of 
high biologic value for the dietetic alleviation of the uremia. The 
results of his study suggest that urea nitrogen can be utilized for 
synthesis of non-essential amino acids if urea is either given 
exogenously to non-uremic subjects or if derived endogenously from 
retained urea in patients with renal failure. 
The results of the Giordano study were corroborated by Giovannetti 
and Maggiore (8) the following year (1964). Again, a diet which pro-
vided only the minimal amount of essential amino acids plus adequate 
energy was found to alleviate the symptoms of azotemic patients while 
resulting in a positive nitrogen balance. All of these studies are 
based on the utilization of endogenous urea by the patient as a source 
of nitrogen for synthesis of non-essential amino acids. 
Alpha-Keto Acid Analogue Therapy 
As early as 1954, studies were under way to modify the concept of 
~ 
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indispensability of "essential amino acids". It has been reported that 
young rats grew as well when five different keto acid analogues were 
used in a diet to replace their corresponding amino acids (21). In 
1971, Gallina et al. (5) reported that a young woman maintained a posi-
tive nitrogen balance when alpha-ketoisovaleric acid was added to a diet 
deficient in valine. Later that same year, Richard et al. (13) reported 
that at least two of the eight essential amino acids could be replaced 
by the alpha-keto analogue in the diet of healthy and uremic patients. 
The administration of this diet resulted in either a positive nitrogen 
balance or a reduced negative nitrogen balance. Also, in 1970, Rudman 
(15) reported that man could convert alpha-ketoisovaleric acid and 
phenylpyruvic acid to the essential amino acids, valine and phenyl-
alanine, even though the efficiency of these conversions was consider-
ably less than 100 percent. 
Significance of Blood Urea Nitrogen Levels 
The significance of urea in the clinical syn,drome of uremia remains 
somewhat controversial (18). Urea itself is non-toxic, so the symptoms 
of uremia are not caused by its accumulation. Thus a substance capable 
of reducing blood urea may or may not be beneficial for the uremic 
patient if this is its only action (20). 
The most common cause for an increased concentration of blood urea 
nitrogen is impaired kidney function. Blood urea nitrogen levels are 
certainly indicative of a disease process in which kidney function is 
hampered so that harmful substances accumulate in the body (17). Con-
sequently, the blood urea concentration is a useful indication of the 
.· 
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course of kidney disease. Clinical improvement almost always results 
when blood urea nitrogen levels decrease and are brought within the 
normal range. Generally, alleviation of uremic symptoms (as indicated 
by BUN levels) is by the restriction of dietary protein. If an agent 
could be added to the diet that would promote nitrogen anabolism by 
directing ammonia derived from intestinal ureolysis to protein synthesis, 
clinical improvement can also be achieved. Reduction of urea nitrogen 
levels in the blood would continue to serve as an indicator for such a 
reaction (20). 
CHAPTER III 
MATERIALS AND METHODS 
Male weanling (approximately three weeks old) rats of the Sprague-
Dawley strain,1 weighing 50 to 75 grams were used in the st~dy. Upon 
arrival they were inunediately transferred to randomly assigned individual 
stainless steel cages. The animals were held three days to compensate 
for any dehydration or starvation effects of shipping before taking 
initial weight and BUN measurements. During this period the animals 
were fed commercial rat ration and water ad lib. 
Eight animals were used for surgical practice and for determining 
rapidity of the onset of uremia following nephrectomy. The surgical 
procedure (Appendix A) was modified when six of the nephrectomized rats 
died due to hemorrhage and surgical trauma. In the surviving rats, the 
ur~mic syndrome appeared within 36 hours, as determined by BUN levels 
(Appendix B). Consequently, it was decided to place the rats on the 
test diets inunediately following surgery. 
Sixteen of the initial twenty test rats survived the surgical 
procedure and were paired for dietary assignment. Test Diets A and Test 
Diet B (Appendices C and D) were randomly assigned within pairs. In the 
evening of Day O, Day 5, Day 10 and Day 15, each rat was weighed and 
bled by the tail-clipping method (Appendix E). Analysis of variance 
1 The rats were purchased from the Sprague-Dawley Company, P. O. Box 
4220, Madison, Wisconsin 53711. 
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(AOV) was made on the data obtained for significant differences in 
performance. Following measurements on Day 15, all animals were 
euthanized. 
9 
CHAPTER IV 
RESULTS AND DISCUSSION 
The results are shown in Figure 1. In both diet treatments, the 
weight gain was rapid for the first five days and then essentially 
plateaued for the next ten days. Gains did not differ due to treatment 
(P > 0.5), as shown in Table I. 
TABLE I 
F SCORE REFLECTING DIFFERENCES IN WEIGHT 
GAINS BETWEEN TREATMENT METHODS 
Treatment Methods 
Diet A (10 EAA) 
Diet B (9 EAA + analogue) 
x 
gm. 
149.89 
146.84 
F 
3.09 
Level of 
Significance 
NS 
The BUN levels rapidly declined during the first five days then 
stabilized for the next ten days. The mean urea-nitrogen level was 
lower (P < .001) with Diet B (8.84 mg%) than Diet A (13.5 mg%) as shown 
in Table II. These data would suggest that the amount of urea synthesis 
was reduced by the uptake of ammonia for the synthesis of amino acids 
from the keto analogues in Diet B. 
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Figure 1. Influence of Diet on Weight Gain and Blood Urea 
TABLE II 
F SCORES REFLECTING DIFFERENCES IN BUN 
LEVELS BETWEEN TREATMENT METHODS 
x 
12 
Level of 
Treatment Methods mg% F Significance 
Diet A (10 EAA) 13.50 
28.74 .001 
Diet B (9 EAA + analogue) 8.84 
Results of this study confirmed previous work cited, showing that 
the alpha-keto analogue of phenylalanine can replace phenylalanine and 
tyrosine in the diet of rats. It was also indicated that urea recycling 
is reduced by the uptake of ammonia for amino acid synthesis. 
The reason for leveling-off effect of BUN levels is unclear. How-
ever, several possibilities have been suggested in previous studies. 
Wood and Cooley (21) suggest that keto acids are unstable and partially 
unusable, so that they cannot be considered equivalent to the amino 
acids on a molecular basis. It may be necessary to supply an analogue 
at a level greater than equimolar amounts. 
The data suggest that the analogues are not converted at 100% 
efficiency as evidenced by the beginning upswing of the BUN levels of 
the rats on Diet B containing the analogue. Hence it is possible that 
· the level of analogue presented is insufficient to sustain amino acid 
synthesis for prolonged periods. 
The whole mechanism of analogue therapy is dependent on high 
caloric intake. It is possible that even though these diets were high 
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enough in calories, food was not consumed in large enough amounts for 
enough calories to be present for sustained amino acid synthesis as the 
rat grew larger. Since weanling rats were used, it was expected that an 
accelerated growth phase would be encountered. However, the diets may 
not have provided enough calories for the additional stress of the 
growth phase. 
As the project neared termination, space became a problem. The 
cages became too small for the rats. Literature suggests that over-
crowding can decrease feed efficiency due to psychological factors. 
This may be one consideration for the plateau of weight gain for both 
diets. Since food intake was not measured, it cannot be stated def-
initely that t~is was the problem, but environmental conditions should 
definitely be considere'd in future studies. 
The whole area of enzyme kinetics and turnover rate was unexplored 
in this study. Problems involving synthesis rate both in the liver and 
muscle tissues may account for the plateau of BUN levels. However, 
further study would be needed before any far-reaching implications could 
be stated. 
CHAPTER V 
SUMMARY, IMPLICATIONS, AND RECOMMENDATIONS 
The effect of the alpha-keto acid analogue substitution for phenyl-
alanine and tyrosine on uremia was investigated. The experimental units 
were sixteen surviving surgically-induced uremic rats. After surgery 
and onset of uremia, the animals were paired and randomly assigned diets 
within each block. Both diets consisted of a basal diet plus an amino 
acid mixture, with Treatment A containing phenylalanine and tyrosine and 
Treatment B containing the alpha-keto acid analogue of phenylalanine. 
Weight gains and blood urea nitrogen levels were observed for a · 
fifteen day period at five day intervals. Statistical analysis revealed 
no statistical significance on weight gain between treatments. However, 
the BUN levels for Treatment B were significantly lower (P < .001) than 
for Treatment A. The results of this experimental study indicate that 
alpha-keto acid analogue therapy is an effective therapy for uremia. 
Implications 
Implications from the data generated in this study are: 
1. Alpha-keto acid analogues will be helpful in alleviating the 
uremic syndrome for short durations. 
2. A synthetic, low protein diet containing one or more alpha-keto 
acid analogues could be used intermittantly with dialysis, thus 
reducing cost of therapy and discomfort for the patient. 
14 
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3. Since alpha-keto analogues can be used for the in vivo synthe-
sis of essential amino acids, it is within the realm of pos-
sibility that di~t therapy for inborn metabolic errors 
involving essential amino acids (particularly phenylalanine) 
may include the use of alpha-keto analogues in the future. 
Recommendations 
Recommendations for further research are: 
1. Extend the number of days of data collection, using a larger 
population in a carefully controlled environment. This 
researcher would suggest a population of 30 weanling rats. 
Amount of ration consumed daily should also be measured to 
estimate food intake efficiency. 
2. Experiment with varying levels of caloric content of diet to 
establish optimum caloric intake. 
3. Replications or expansioris of this study should incorporate the 
experimental diet in pelletized form. 
4. Pariorbital bleeding technique for the collection of blood 
samples should be used instead of the tail bleeding method used 
in this study. 
5. Substitute two or more alpha-keto analogues at different levels 
to study nutrient interactions and to establish optimum levels 
of supplementation. 
6. Using perfusion techniques, investigate the enzyme activity and 
turnover rates in the liver and various muscles for each amino 
acid analogue under investigation. 
(1) 
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
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Procedure for Surgically-Induced Uremial 
The rats were anesthetised with nembutal (1 cc. of a 60 mg./ml. 
solution in 8.13 cc. sterile saline) and the upper and lower poles of 
the left kidney were removed, leaving the pelvis and hilum intact 
(Figure 2). Bleeding was controlled by the application of silicone gel 
foam. One week later, the whole right kidney was removed. Care was 
taken to preserve the suprarenal glands and their vascular connections. 
The approach on each occasion was laterally. Before closure, the 
surgical incision was sprayed with 50 x 103 units sodium penicillin on 
each operation to control urinary infections and possible infection of 
the surgical site. 
1 
L 
cJ L ... , 
.. ·~~ 
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Figure 2. The Extent of the Nephrectomies. The 
.parts of the kidneys which were 
removed are shown with a broken 
outline. 
Adapted from Platt, R. Roscoe, M. H. and F. W. Smith. "Experi-
me~tal Renal Failure." Clinical Science, Vol. 11. (1952), pp. 217-231. 
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Procedure for Determination of Blood Urea 
by Urease and the Berthelot Reaction 
1 (Method of Chaney and Marbach) 
1. Set up the following in test tube (or cuvets, e.g. Klett tubes, if 
their capacity if sufficient) : 
Blank - 0. 2 ml. buffered urease solution. 
Standard - 0. 2 ml. buffered urease solution + 20 µl. urea 
standard. 
Unknown - 0.2 ml. buffered urease solution + 20 µl. serum. 
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(The 20 µl. aliquots of standard and unknown are added by TC micro 
pipets, Sahli hemoglobin pipets being satisfactory if their accuracy 
has been checked.) 
2. Incubate tubes in a water bath at 37°C. for 15 minutes. 
3. Add 1. 0 ml. pheno 1 color reagent to each tube, mix, then 1. 0 ml. 
alkali-hypochlorite reagent anc;l mix promptly again. It is mandatory 
that the phenol reagent be added and mixed first! 
4. Incubate tubes at 50-60°C for 3 minutes, at 37°C for 20 minutes or 
at 25°C for 40 minutes. 
5. Add water equally to all tubes to bring absorbance readings into 
desirable absorbance range (preferably 0.2-0.8). For Beckman DU 
with 1 cm. cuvets, add 8.0 ml. water, and for Klett photometer using 
No. 54 filter, add 3.0 ml. water~ Do not use bare thumb if mixing 
must be accomplished by inversion; clean Saran Wrap (Dow Chemical) 
or Parafilm "M" (Marathon) can be used with the thumb. 
6. Read absorbances of blank (Ab), standard (As) and unknown (Ax) 
against water at 630 MU or with a filter with nominal wavelength in 
this region. If~ is greater than"0.8, dilute the blank and unknown 
further with water equally, read absorbances again, and make proper 
corrections in calculations. 
7. Calculations: 
Mg. urea N/100 ml. 
serum or plasma 
1Henry, R. J. Clinical Chemistry: Principles and Technics. Harper 
& Row Publishers, New York. (1965), pp. 266-268. 
APPENDIX C 
COMPOSITION OF BASAL DIET 
22 
23 
Composition of Basal Diet 
gm./kg: diet 
Dextrin 
Vitamin mixturea 
Choline mixtureb 
Mineral mix 4164 
Cellulose 
NaCl 
Corn Oil 
Essential amino acid mixtureC 
Non-essential amino acid mixturec 
TOTAL 
675.0 
7.5 
7.5 
40.0 
20.0 
10.0 
40.0 
100.0 
100.0 
1000. 0 
aTo provide: in mg/kg; thiamin HCl, 15; riboflavin, 15; Ca 
pantothenate, 75; pyrodixine HCl, 75; nicotinic acid, 30; folic acid, 3; 
PABA, 75; menadione, 0.15; biotin, 0.15; vitamin B-12 in mannitol 
(0.1%), 0.3; inositol, 492; Vitamin A-palmitate (250,000), 4,100 IU; 
ergocalciferol, 12,69 IU. 
bContained choline chloride in sucrose (13.2%), 400 IU/kg. diet. 
cAs listed in appendix table D. 
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Composition of Basal Amino Acid Mixtures 
Essential Amino Acids 
L-Arginine HCl 
L-Histidine HCl·H20 
L-Isoleucine 
L-Leucine 
L-Lysine HCl 
L-Methionine 
L-Threonine 
L-Tryptophan 
L-Valine 
L-Phenylalaninel 
Dextrin (from total) 
TOTAL 
Non-es'sential Amino Acids 
DL-Alanine 
L-Asparagine·H20 
L-Aspartic acia: 
L-Cystine 
L-Glutamic acid 
L-Glycine 
L-Proline 
DL-Serine 
L-Tyrosine2 
Dextrin (from total) 
TOTAL 
25 
gm. /kg. diet 
4.00 
3.27 
4.20 
5.85 
7.50 
2.25 
3.87 
1. 30 
5.20 
3.75 
62.64 
100.00 
gm./kg. diet 
2.30 
3.95 
2.30 
3.50 
27.30 
13.95 
2.30 
2.30 
4.00 
38.00 
100.00 
1When phenylalanine is replaced by its analogue (phenylpyruvic acid) 
on an equimolar basis, dextrin will be added as filler. 
2when tyrosine is omitted when the phenylalanine is replaced by its 
analogue (phenylpyruvic acid) on an equimolar basis, dextrin will be 
added as filler. 
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1 Procedure for Collecting Blood Samples 
27 
1. Wrap the rat firmly in a small towel with only its head and tail 
protruding. This procedure serves the double purpose of keeping the 
rat warm (essential for successful bleeding) and making it easier 
for th~ assistant to restrain the rat while the blood is obtained by 
the operator. 
2. Immerse the rat's tail for 1-2 minutes in warm water in a conical 
flask or other suitable receptable large enough to permit immersion 
of nearly the whole length of tail. The temperature of the water 
should be about 45°C. and some antiseptic should be added. 
3. Remove the tail from the water and wipe quickly with cotton. 
4. Swab the tail in quick succession with alcohol and xylol, thus remov-
ing all water from the surface of the tail and dilating the tail 
vessels. 
5. Wipe the tail free from xylol. 
6. Place the tail on a pad of clea~ filter paper on the bench, steady 
the tip of the tail by holding it between thumb and forefinger of 
the left hand so that only about a quarter-of-an-inch protrudes; 
then with a sharp sterilized scalpel (or safety razor blade) deftly 
remove a tiny slice from the tail tip. It is essential for the suc-
cess of future bleedings to remove the smallest possible piece of 
tail. 
7. The blood samples can now be sucked into the pipettes or the blood 
allowed to drip into a heparinized or oxalated tube coated with 
paraffin wax. . It may be necessary to run the forefinger and thumb 
gently down the tail to expel the blood but this action should never 
become a vigorous squeezing. If the blood should refuse to flow, 
repeat the preparatory steps through hot water, alcohol, xylol, etc. 
8. When the desired amount of blood has been obtained the tail is 
thoroughly swabbed with a 0.1 percent solution of acriflavine to 
prevent infection before returning the rat to its cage. If the tail 
bleeds excessively, a solution of collodion may be used to cover the 
excision line. 
1 Worden, A. N. and A. Lane-Petter. The UFAW Handbook on the Care 
-- --- -- -- --
and Management£!.. Laboratory Animals, 2nd edition. Courier Printing and 
Publishing Co., Ltd., Kent, England. (1957), pp. 368-369. 
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INDIVIDUAL RECORD 
Rat No. 
------
Initial Wt._· _____ _ Initial BUN_· ____ _ 
Block ________ _ L. Kidney removed: ______ _ 
Treatment ____ _ R. Kidney removed: ______ _ 
Day 0 Day 5 Day 10 Day 15 
Date 
----
Date 
----
Date 
----
Date ___ _ 
Wt. 
BUN 
------
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